Plain-English translation of NCT07216703 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new medication called combined with (an immunotherapy drug) to treat cervical cancer that has spread or come back. The study will compare this new combination to standard care to see if it helps people live longer and control their cancer better. You may also receive , another cancer medication, depending on what your doctor thinks is best.
Current treatments for advanced cervical cancer don't work well enough for all patients. Researchers believe combining this new medication with immunotherapy might be more effective than standard treatment alone.
You likely qualify if…
You likely don't qualify if…
The study happens in two parts. First, you receive standard chemotherapy combined with for about 4 months (given every 3 weeks in 6 cycles). If your cancer doesn't get worse, you move to the maintenance phase where you receive the new medication and for up to 20 months. You'll visit the hospital or clinic regularly for infusions and checkups, and your doctors will monitor you closely for side effects.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States